论文部分内容阅读
目的分析和探讨洛伐他汀片联合复方丹参滴丸在治疗过程中安全性。方法 55例冠心病伴高血脂的患者,随机分为对照组(27例)和观察组(28例),对照组患者仅给予洛伐他汀单药口服治疗,观察组患者在给洛伐他汀口服治疗的同时给予复方丹参滴丸口服,对比采取两种不同的药物组合方案的临床治疗总有效率。结果对照组患者的临床治疗总有效率70.37%明显低于观察组的89.29%,两组比较差异具有统计学意义(P<0.05)。结论对于高血脂伴冠心病的患者采用洛伐他汀联合复方丹参滴丸治疗治疗,效果显著,可以有效预防不良事件的发生,值得临床推广。
Objective To analyze and explore the safety of lovastatin tablet and compound Danshen dripping pills in the course of treatment. Methods Fifty-five patients with coronary heart disease and hyperlipidemia were randomly divided into control group (n = 27) and observation group (n = 28). Patients in the control group were treated with lovastatin alone. Patients in the observation group were orally given lovastatin At the same time, compound Danshen dripping pills were given orally, comparing the total effective rate of clinical treatment with two different drug combination regimens. Results The total effective rate of clinical treatment was 70.37% in the control group was significantly lower than 89.29% in the observation group, the difference was statistically significant (P <0.05). Conclusion For patients with hyperlipidemia and coronary heart disease, lovastatin combined with compound Danshen dripping pills is effective and effective in preventing the occurrence of adverse events and is worthy of clinical promotion.